Select a Region North America

Expertise

Sharon Donofrio, Consultant, Patient Access

Sharon Donofrio

Consultant, Patient Access

Expertise:

Market Access, Market Research, Specialty & Direct-to-Patient Distribution

Sharon Donofrio, PharmD is a Consultant for the Patient Services team at EVERSANA, responsible for leading our specialty pharmacy focused product line. Sharon has a strong knowledge of pharmaceutical market access strategies and challenges among leading payers including leading health plans, PBMs, and payer-owned specialty pharmacies.

Sharon was previously a Specialty Pharmacy Manager with Walgreens, where she launched and operated a specialty pharmacy, enabling her to build strategic relationships with pharmaceutical companies, local health systems, insurance companies, and providers leading to LDN access. While at Walgreens, She developed a ‘meds to beds’ program streamlining patient access to medication, reducing readmission rates, and improving patient satisfaction scores, and successfully introduced operational improvement plans resulting in marked revenue growth.

Sharon received her Doctorate in Pharmacy from Massachusetts College of Pharmacy and Health Sciences and her Bachelor’s degree in Biology from Loyola College.

Articles by Sharon Donofrio

Biosimilars and Specialty Pharmacy
Specialty Pharmacies are Ready for the Biosimilar Boom. Are you?

The pharmacy benefit biologic market is primed for disruption, with Specialty Pharmacies (SPs) eagerly awaiting the pending market shift. While biosimilars have been available for nearly a decade in the United States, this year will be the first time many SPs begin dispensing these brands. Currently, 22 biosimilars are available in the U.S. and, up until recently, nearly all 17 of these brands fell within the therapeutic area of oncology/oncology support markets, where insurance coverage is typically billed through the medical benefit. Unlike many oncolytic biosimilars, several (if not all) of the newly available or soon-to-launch autoimmune biosimilars are self-administered products, which will largely be covered by the patient’s pharmacy […]

Interested in scheduling a meeting or speaking event?

お問い合わせ